NCT06915025 2026-02-27
OVATION-3
Imunon
Phase 3 Recruiting
Clinical Trials
4 trialsNCT01489371 2019-03-12
EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
GOG Foundation
Phase 1 Completed
NCT00473954 2013-03-26
Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer
EGEN, Inc.
Phase 1 Completed
NCT00137865 2013-02-28
Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer
EGEN, Inc.
Phase 1 Terminated